Table 1

Segmented regression of time-series results expressed in defined daily doses—prescription of anxiolytics, sedatives and hypnotics

Immediate impactChange in trendAbsolute change in outcome a month after COVID-19Relative change in outcome a month after COVID-19 (%)
B95% CIB95% CI
Male
 Children (≥7 yo)−3795.81*−5361.47 to −2230.15−0.36−179.70 to 178.99−3796.17−47.60
 Adolescents (8–17 yo)−2899.09*−5673.12 to −125.05122.73−188.30 to 433.77−2776.35−10.57
 Adults (18–64 yo)−168 291.27−439 366.75 to 102 784.2127 129.40−3468.68 to 57 727.48−141 161.87−5.74
 Older adults (65–74 yo)−34 403.70−100 896.53 to 32 089.1413 162.11*4929.03 to 21 395.18−21 241.59−1.58
 Elderly (≥75 yo)−30 939.04−94 317.29 to 32 439.2014 582.46*6863.67 to 22 301.26−16 356.58−1.25
Female
 Children (≥7 yo)−2938.74*−3966.10 to −1911.38−26.05−133.60 to 81.50−2964.79−47.82
 Adolescents (8–17 yo)−7142.78*−12 399.81 to −1885.75521.04−5.99 to 1048.07−6621.74−27.46
 Adults (18–64 yo)−80 580.27−676 807.98 to 515 647.4445 887.32−23 833.17 to 115 607.81−34 692.95−0.77
 Older adults (65–74 yo)−186 383.98−374 446.64 to 1678.6740 328.93*17 743.87 to 62 913.98−146 055.06−4.50
 Elderly (≥75 yo)−330 938.28*−516 988.89 to −144887.6655 986.34*34 033.34 to 77 939.34−274 951.94−7.20
 Total−724 445.94−1 881 469.52 to 432 577.63185 245.64*40 314.44 to 330 176.85−539 200.30−3.37
  • The impact of the COVID-19 pandemic on the prescription of antidepressants.

  • *p<0.05